This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…. The post Customer Success: How do we identify generic entrants before they get FDA approval? appeared first on DrugPatentWatch - Make Better Decisions.
To succeed in today’s highly competitive pharmaceutical landscape, differentiation is key. In recent years, many. The post The Opportunity for Generics Companies and Value Added Medicines in the US and Europe appeared first on Camargo.
This cohort study examines the risk of bleeding and stroke associated with surgical procedures and the value of perioperative management among patients with atrial fibrillation who use anticoagulants.
STEPS TO START A PHARMACEUTICAL DISTRIBUTION COMPANY. When the pharma secto r is touching new heights year after year, it is a great idea to take the business benefits from it. Due to technological and scientific advances, pharmaceutical innovations are happening every second day. It means the opportunities are more than ever, especially if you are an enthusiastic entrepreneur.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Use Halloween to Your Advantage Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a voice mess
At first, it may seem like your diagnosis only changes the big things – you now have to manage a chronic illness, adjust your treatment as needed, learn to recognise symptoms, be prepared for a myasthenic crisis , etc. Fatigue makes everyday life harder and you may feel frustrated, ashamed or vulnerable for needing assistance with simple tasks that took no effort before. .
The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…. The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch - Make Better Decisions.
The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…. The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch - Make Better Decisions.
Last Updated: 1 November 2022 Syneos Health (“we,” “us,” or “Syneos Health”), operating through its affiliates/subsidiaries located throughout the world (collectively, the “Co
This cohort study examines whether soft drink consumption is associated with all-cause and cause-specific mortality in a large cohort of European adults.
Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies). Payers are in a difficult spot regarding the cost and management of these regimens. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying tr
Use Halloween to Your Advantage. Don't forget to Subscribe for new content! Subscribe: [link]. Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link]. We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Being the loved one of someone who recently got diagnosed with Myasthenia Gravis is never easy but it can be even harder if you also happen to be their caregiver. If your spouse, child or parent got diagnosed with MG after some time of uncertainty, symptoms with no explanation, or at the opposite end of the spectrum – all of a sudden with no prior warning the disease manifested itself… it can come as both a relief and a shock.
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…. The post Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 appeared first on DrugPatentWatch - Make Better Decisions.
A few weeks back, I wrote about the House Ways and Means Committee international drug price report, which very competently compared U.S. patented drug prices with 11 other countries. The report found that 79 drugs, ones that account for 60% of Medicare drug spending, are on average priced just under 75% lower internationally vs. the U.S. when looking at ex-factory, meaning wholesale prices.
Should I Get A Clinical Research Certificate? In this episode we discuss those clinical research certifications and if they mean anything or if they can even help you get into the industry or get to your dream job. You may have heard about the CCRA, CCRP and many other ones. Hope this episode helps. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Wat
Should I Get A Clinical Research Certificate? In this episode we discuss those clinical research certifications and if they mean anything or if they can even help you get into the industry or get to your dream job. You may have heard about the CCRA, CCRP and many other ones. Hope this episode helps. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Wat
Meeting Metrics As A CRA In this episode we discuss what metrics CRA's have to meet. As many of you know Clinical Research Associates are very busy but why is that? The metrics they have to meet are a big reason for that. Stay tuned for an upcoming episode on the metric differences between the pharma world and CRO world. Don't forget to Subscribe for new content!
Meeting Metrics As A CRA. In this episode we discuss what metrics CRA's have to meet. As many of you know Clinical Research Associates are very busy but why is that? The metrics they have to meet are a big reason for that. Stay tuned for an upcoming episode on the metric differences between the pharma world and CRO world. Don't forget to Subscribe for new content!
Upsides and Downsides of Being a CRA In this episode we discuss the upsides and downsides of being a CRA. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Cli
Upsides and Downsides of Being a CRA. In this episode we discuss the upsides and downsides of being a CRA. Don't forget to Subscribe for new content! Subscribe: [link]. Call or Text: 910-502-3732. Email: eliteclinicalgroup@gmail.com. Podcast: [link]. Steemit: [link]. Advertise: eliteclinicalgroup@gmail.com. Watch: » Industry News: [link] ». All Videos: [link] ».
October is dedicated to raising awareness about breast cancer and there are many more things healthcare professionals, health blogs and journals and even patients can do to participate in addition to wearing a pink ribbon. If you follow our blog you know that we at FindMeCure take updating our readership on treatments in development very seriously. Drugs and therapies under study are our hope for the future of healthcare, so taking the time to learn more about them is an investment in your futur
CRA Tells The Truth About CRA Career Progression In this episode a CRA tells the truth about Career Progression in the clinical research field. Clinical research associate career progression. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Send in a voice message: [link] CRA Tells The Truth About CRA Career Progression In this episode a CRA tells the
CRA Tells The Truth About CRA Career Progression In this episode a CRA tells the truth about Career Progression in the clinical research field. Clinical research associate career progression. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
How She Went From CTA to CRA There are many of you all out there who want to be CRA's and are currently CTAs. Here is how one person went from being a CTA to a CRA. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Send in a voice message: [link] How She Went From CTA to CRA There are many of you all out there who want to be CRA's and are currently CTA
How She Went From CTA to CRA There are many of you all out there who want to be CRA's and are currently CTAs. Here is how one person went from being a CTA to a CRA. Don't forget to Subscribe for new content! Subscribe: [link]. Call or Text: 910-502-3732. Email: eliteclinicalgroup@gmail.com. Podcast: [link]. Steemit: [link]. Advertise: eliteclinicalgroup@gmail.com.
We can’t not celebrate Health Literacy Awareness Month ! It has always been one of FindMeCure ’s missions to raise awareness about healthcare innovation and give patients the means to make informed decisions about their treatment in a comprehensible and down-to-earth way. We believe that knowledge is power and we would like to see empowered patient communities full of people taking their health in their own hands. .
How An Internship Helped This CRA Launch Her Career Internships are one of the greatest ways to get your start in clinical research. Enjoy hearing the story of how this CRA got her start through an internship! Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Send in a voice message: [link] How An Internship Helped This CRA Launch Her Career Internship
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How An Internship Helped This CRA Launch Her Career Internships are one of the greatest ways to get your start in clinical research. Enjoy hearing the story of how this CRA got her start through an internship! Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com.
The FDA has finished draft guidance on one of two of the Trump administration’s drug importation policy ideas, referred to as Pathway II. The title of this post may seem like a joke for those of you who follow the issue of drug importation in America, but it is real. As a reminder, in August 2019 the administration took its support for drug importation a step further by stating its willingness to support state drug importation programs, Pathway I, and a new idea to give drug companies greater fl
This week, journalist Ben Elgin of Bloomberg published an exceedingly thorough and investigative report about how the Partnership for Safe Medicines (PSM), funded by the Pharmaceutical Researchers and Manufacturers of America (PhRMA), is behind a massive campaign to defeat drug importation proposals that seek to lower drug prices. In fact, the report disclosed that PSM apparently received $7 million in 2017 to oppose importation.
If you care about and follow the issue of drug prices, then this week was bizarre on the political scene. In a press conference with Rep. Adam Schiff (D-CA) at her side, Speaker of the House Nancy Pelosi (D-CA) was imploring the media not to focus only on impeachment but on drug prices, noting that she believes Congress and President Trump can continue to work together despite the friction.
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content